Sector: MedicalREPROS THERAPEUTICS (NASDAQ: RPRX)
Headlines
- Repros Appoints Dr. Jaye Thompson to Board of Directors
Nov 12, 2009 02:49 PM | RPRX
- Repros to Appeal NASDAQ Delisting Notice
Nov 09, 2009 08:01 PM | NDAQ, RPRX
- Repros Therapeutics Inc. Reports Third Quarter 2009 Financial Results
Nov 09, 2009 06:00 AM | RPRX
- Repros Therapeutics Announces Settlement with Major Creditors
Oct 30, 2009 06:59 AM | RPRX
- Repros Therapeutics Announces Amendment of NIH Proellex(R) License
Oct 28, 2009 08:01 PM | RPRX
- Repros Therapeutics Inc. Announces Financing
Oct 08, 2009 09:45 AM | RPRX
- Repros Reports Androxal(R) Restores Normal Sperm Counts While Increasing Testosterone Levels in Hypogonadal Men
Oct 06, 2009 09:00 PM | AUXL, RPRX
- Repros Proellex Under FDA Microscope (RPRX)
Sep 30, 2009 02:52 PM | RPRX
- Pre-Market: Caution Returns To Wall Street - Stock Futures Indicate Modestly Lower Start
Sep 29, 2009 09:20 AM | ABT, ACS, CIT, RPRX, SQNM, SSTI
- Repros Therapeutics Inc. Provides Update on Proellex
Sep 29, 2009 06:30 AM | RPRX
- Repros to Appeal NASDAQ Delisting Notice
Nov 10, 2009 01:11 AM | RPRX
- Repros Therapeutics Inc. Receives Additional NASDAQ Delisting Notice
Sep 21, 2009 10:17 AM | RPRX
- The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Repros Therapeutics Inc.
Aug 17, 2009 12:33 PM | RPRX
- Brower Piven Encourages Investors Who Have Losses in Excess of $50,000 From Investment in Repros Therapeutics, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the October 6, 2009 Lead Plaintiff Deadline
Aug 14, 2009 08:00 PM | RPRX
- Charles H. Johnson & Associates Announces Filing of Securities Class Action Against Repros Therapeutics, Inc.
Aug 12, 2009 03:23 PM | RPRX
- Izard Nobel LLP Announces Class Action Lawsuit Against Repros Therapeutics, Inc.
Aug 11, 2009 05:20 PM | RPRX
- Kendall Law Group Announces Class Action Against Repros Therapeutics, Inc.
Aug 11, 2009 04:42 PM | RPRX
- Holzer Holzer & Fistel, LLC Announces That a Shareholder Class Action Has Been Filed on Behalf of Investors in Repros Therapeutics, Inc.
Aug 11, 2009 04:24 PM | RPRX
- Repros Announces Class Action Lawsuit Filed Against It and Certain of Its Officers and Directors, and Also Announces Receipt of Notice from NASDAQ of Non-Compliance with Listing Standards
Aug 11, 2009 06:02 AM | RPRX
- Emerson Poynter LLP Announces the Filing of a Class Action Lawsuit Against Repros Therapeutics, Inc. -- RPRX
Aug 10, 2009 05:30 PM | RPRX
- Form 4 REPROS THERAPEUTICS INC. For: Nov 12 Filed by: Thompson Jaye (10K)
Nov 20, 2009 06:37 PM
- Form 3 REPROS THERAPEUTICS INC. For: Nov 12 Filed by: Thompson Jaye (10K)
Nov 20, 2009 06:35 PM
- Form 3 REPROS THERAPEUTICS INC. For: Oct 29 Filed by: Anderson Katherine (10K)
Nov 12, 2009 09:58 AM
- Form 4 REPROS THERAPEUTICS INC. For: May 20 Filed by: CAIN DANIEL F (10K)
May 22, 2009 05:36 PM
- Form 4 Lappe Mark For: May 20 (10K)
May 22, 2009 05:35 PM
- Form 4 Masterson Nola E For: May 20 (10K)
May 22, 2009 05:34 PM
- Form 4 REPROS THERAPEUTICS INC. For: May 20 Filed by: REED JOHN C (10K)
May 22, 2009 05:33 PM
- Form 4 FOURCROY JEAN L MD PHD For: May 20 (10K)
May 22, 2009 05:32 PM
- Form 4 Howell Stephen B. For: May 20 (10K)
May 22, 2009 05:29 PM
- Form 3 Howell Stephen B. For: May 20 (10K)
May 22, 2009 05:28 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
RPRX
|
Compare to S&P
|
| YTD |
-93.16 %
|
-94.34 %
|
| 4 Weeks |
-42.41 %
|
-43.03 %
|
| 12 Weeks |
-20.89 %
|
-25.42 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -11.86 %
|
|
EPS Growth in Last Year: -29.41 %
|
|
Sales Growth in Last Quarter: -66.67 %
|
|
Sales Growth in Last Quarter: -98.90 %
|
|
